Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8533 |
High Similarity |
NPD1653 |
Approved |
0.8483 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8141 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8072 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8072 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7875 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD7054 |
Approved |
0.775 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7746 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7725 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7692 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7665 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7633 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7584 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7574 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7551 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7228 |
Approved |
0.75 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7457 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7439 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.741 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7403 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7397 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7396 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7381 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD37 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7262 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7261 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7234 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7228 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7226 |
Intermediate Similarity |
NPD290 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7202 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7192 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.719 |
Intermediate Similarity |
NPD1933 |
Approved |
0.719 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.7184 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1778 |
Approved |
0.717 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7153 |
Intermediate Similarity |
NPD968 |
Approved |
0.7152 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7115 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7114 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.709 |
Intermediate Similarity |
NPD7874 |
Approved |
0.709 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7065 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7065 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7047 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7044 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7044 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7043 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7043 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7037 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7012 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7 |
Intermediate Similarity |
NPD1203 |
Approved |
0.6993 |
Remote Similarity |
NPD7985 |
Registered |
0.6993 |
Remote Similarity |
NPD3268 |
Approved |
0.6988 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6987 |
Remote Similarity |
NPD4538 |
Approved |
0.6987 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD4536 |
Approved |
0.6986 |
Remote Similarity |
NPD5585 |
Approved |
0.6984 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.698 |
Remote Similarity |
NPD4749 |
Approved |
0.6978 |
Remote Similarity |
NPD1358 |
Approved |
0.6972 |
Remote Similarity |
NPD5535 |
Approved |
0.6968 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD447 |
Suspended |
0.6959 |
Remote Similarity |
NPD1611 |
Approved |
0.6947 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6946 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD7157 |
Approved |
0.6927 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6913 |
Remote Similarity |
NPD1608 |
Approved |
0.6903 |
Remote Similarity |
NPD4140 |
Approved |
0.6901 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6875 |
Remote Similarity |
NPD6184 |
Discontinued |
0.6875 |
Remote Similarity |
NPD7801 |
Approved |
0.6871 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD1357 |
Approved |
0.6871 |
Remote Similarity |
NPD7447 |
Phase 1 |
0.6865 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6865 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6864 |
Remote Similarity |
NPD3882 |
Suspended |
0.6862 |
Remote Similarity |
NPD7680 |
Approved |
0.686 |
Remote Similarity |
NPD6232 |
Discontinued |
0.6855 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6855 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6855 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6855 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6846 |
Remote Similarity |
NPD1535 |
Discovery |
0.6846 |
Remote Similarity |
NPD3705 |
Approved |
0.6842 |
Remote Similarity |
NPD5494 |
Approved |
0.6842 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD4062 |
Phase 3 |
0.6839 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6835 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6835 |
Remote Similarity |
NPD9697 |
Approved |
0.6835 |
Remote Similarity |
NPD5588 |
Approved |
0.6835 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6833 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD6273 |
Approved |
0.6826 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6824 |
Remote Similarity |
NPD4626 |
Approved |
0.6824 |
Remote Similarity |
NPD5126 |
Approved |
0.6824 |
Remote Similarity |
NPD5846 |
Approved |
0.6824 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6821 |
Remote Similarity |
NPD6696 |
Suspended |
0.6818 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.681
|
Remote Similarity |
NPD1511 |
Approved |